Literature DB >> 29189974

Association of SIRT1 gene polymorphism and its expression for the risk of alcoholic fatty liver disease in the Han population.

Yeting Hou1, Bingzhong Su1, Ping Chen1, Haijing Niu1, Sheng Zhao2, Ruijun Wang3, Wei Shen4.   

Abstract

OBJECTIVE: To investigate the associations between SIRT1 polymorphisms and their expression in patients with alcoholic fatty liver disease (AFLD).
METHODS: A total of 268 heavy drinkers were divided into the AFLD group (n = 176) and alcoholic control (n = 92) and 237 light-/non-drinkers into the NAFLD (non-AFLD) group (n = 117) and healthy control (n = 120). The genotyping of SIRT1 (rs33957861, rs11599176, rs12413112 and rs35689145) was detected by the Sequenom MassARRAY iPLEX test. The mRNA and protein expressions of SIRT1 were determined by quantitative real-time polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assays (ELISA), respectively.
RESULTS: SIRT1 gene rs33957861 and rs11599176 polymorphisms significantly reduce the risk of NAFLD and AFLD, while rs35689145 remarkably increases the risk. Haplotypes of AAAA (rs33957861-rs11599176-rs12413112-rs35689145), AAAA, CAGA and CGAA can appreciably lower the presence of AFLD, but CAAG had an elevated AFLD risk. Besides, in the NAFLD and AFLD groups, a decreased BMI was found in the mutant genotype carriers of rs33957861, rs11599176 and rs12413112, but an increased BMI was observed in the rs35689145 mutant genotype carriers when compared to those with the wild-type homozygous genotype ones. Furthermore, rs33957861 C>T, rs11599176 A>G and BMI were independent risk factors of AFLD. There was no difference among four SNPs of SIRT1 and its mRNA and protein expressions in all groups.
CONCLUSION: SIRT1 polymorphisms and their expression were associated with the presence of AFLD, and there was a close relationship among four SNPs and BMI in AFLD patients, but no SNP was related to its expression.

Entities:  

Keywords:  AFLD; Polymorphism; SIRT1; mRNA

Mesh:

Substances:

Year:  2017        PMID: 29189974     DOI: 10.1007/s12072-017-9836-8

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  32 in total

1.  [Pathogenic role of the adiponectin-SIRT 1-AMPK signaling pathway in alcoholic fatty liver disease].

Authors:  Junying Zhou; Yinghui Liu; Dongfang Zhou; Shanyan Nie; Huifang Zhao; Guohua Jin
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2015-09

2.  SIRT1 interacts with metabolic transcriptional factors in the pancreas of insulin-resistant and calorie-restricted rats.

Authors:  Yong-Ru Chen; Yu-Lin Lai; Shao-da Lin; Xi-Tao Li; Yu-Cai Fu; Wen-Can Xu
Journal:  Mol Biol Rep       Date:  2013-01-06       Impact factor: 2.316

3.  Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases.

Authors:  Johannes-W Rey; Andrea Noetel; Aline Hardt; Ali Canbay; Hakan Alakus; Axel Zur Hausen; Hans-Peter Dienes; Uta Drebber; Margarete Odenthal
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

4.  Effects of Angelica dahurica on obesity and fatty liver in mice.

Authors:  Xi Lu; Zhi-Yi Yuan; Xiao-Jin Yan; Fan Lei; Jing-Fei Jiang; Xuan Yu; Xiu-Wei Yang; Dong-Ming Xing; Li-Jun DU
Journal:  Chin J Nat Med       Date:  2016-09

5.  Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines.

Authors:  Zheng Shen; Joanne M Ajmo; Christopher Q Rogers; Xiaomei Liang; Lisa Le; Michel M Murr; Yanhua Peng; Min You
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

Review 6.  Adiponectin and alcoholic fatty liver disease.

Authors:  Christopher Q Rogers; Joanne M Ajmo; Min You
Journal:  IUBMB Life       Date:  2008-12       Impact factor: 3.885

7.  Involvement of mammalian sirtuin 1 in the action of ethanol in the liver.

Authors:  Min You; Xiaomei Liang; Joanne M Ajmo; Gene C Ness
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-31       Impact factor: 4.052

8.  Betulin alleviated ethanol-induced alcoholic liver injury via SIRT1/AMPK signaling pathway.

Authors:  Ting Bai; Yong Yang; You-Li Yao; Peng Sun; Li-Hua Lian; Yan-Ling Wu; Ji-Xing Nan
Journal:  Pharmacol Res       Date:  2016-01-15       Impact factor: 7.658

9.  Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.

Authors:  Huquan Yin; Ming Hu; Xiaomei Liang; Joanne M Ajmo; Xiaoling Li; Ramon Bataller; Gemma Odena; Stanley M Stevens; Min You
Journal:  Gastroenterology       Date:  2013-11-18       Impact factor: 22.682

10.  Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.

Authors:  Yinliang Zhang; Chao Geng; Xiaoyan Liu; Meixia Li; Mingyue Gao; Xiaojun Liu; Fude Fang; Yongsheng Chang
Journal:  Mol Metab       Date:  2016-11-17       Impact factor: 7.422

View more
  1 in total

1.  Complement C3 activation regulates the production of tRNA-derived fragments Gly-tRFs and promotes alcohol-induced liver injury and steatosis.

Authors:  Fudi Zhong; Zhigao Hu; Keqing Jiang; Biao Lei; Zhan Wu; Guandou Yuan; Hongliang Luo; Chunqiang Dong; Bo Tang; Chaowen Zheng; Shuai Yang; Yonglian Zeng; Zhenya Guo; Shuiping Yu; Huizhao Su; Guo Zhang; Xiaoqiang Qiu; Stephen Tomlinson; Songqing He
Journal:  Cell Res       Date:  2019-05-10       Impact factor: 25.617

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.